T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Generac Holdings
GNRC
$13.1B
| $10.1M | ﹤0.01% |
80,064
-1,333
| -2% | -$156K |
|
1102
Home BancShares
HOMB
$6.23B
| $10M | ﹤0.01% |
408,952
+817
| +0.2% | +$19.4K |
|
|
CMA
1103
DELISTED
Comerica
CMA
| $10M | ﹤0.01% |
182,402
+2,636
| +1% | +$138K |
|
|
BCYC
1104
Bicycle Therapeutics
BCYC
$279M
| $10M | ﹤0.01% |
401,646
+124,809
| +45% | +$2.65M |
|
1105
Fidelity National Financial
FNF
$12.8B
| $9.98M | ﹤0.01% |
187,996
+6,084
| +3% | +$307K |
|
1106
Nextpower Inc
NXT
$15.7B
| $9.85M | ﹤0.01% |
175,047
+147,446
| +534% | +$7.84M |
|
1107
Alto Neuroscience
ANRO
$1.26B
| $9.79M | ﹤0.01% |
+637,604
| New | +$9.98M |
|
1108
Flowserve
FLS
$10.3B
| $9.72M | ﹤0.01% |
212,856
-643,063
| -75% | -$27.1M |
|
1109
Pacira BioSciences
PCRX
$924M
| $9.7M | ﹤0.01% |
332,020
-71,733
| -18% | -$2.2M |
|
1110
Voyager Therapeutics
VYGR
$197M
| $9.7M | ﹤0.01% |
1,041,930
+37,144
| +4% | +$314K |
|
1111
Hyatt Hotels
H
$16.8B
| $9.69M | ﹤0.01% |
60,711
-179
| -0.3% | -$25.2K |
|
1112
Mohawk Industries
MHK
$9.27B
| $9.65M | ﹤0.01% |
73,755
+2,112
| +3% | +$237K |
|
1113
iShares Russell 1000 Growth ETF
IWF
$129B
| $9.6M | ﹤0.01% |
113,908
-1,156
| -1% | -$93.1K |
|
1114
Annexon
ANNX
$862M
| $9.49M | ﹤0.01% |
1,323,704
+1,311,195
| +10,482% | +$6.81M |
|
1115
Unity
U
$20.2B
| $9.44M | ﹤0.01% |
353,516
+230,696
| +188% | +$7.25M |
|
1116
Thryv Holdings
THRY
$96.9M
| $9.42M | ﹤0.01% |
423,710
+1,306
| +0.3% | +$27.1K |
|
1117
TAL Education Group
TAL
$6.58B
| $9.37M | ﹤0.01% |
825,853
+810,953
| +5,443% | +$10.1M |
|
1118
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $9.25M | ﹤0.01% |
219,700
-6,000
| -3% | -$251K |
|
|
SNV
1119
DELISTED
Synovus
SNV
| $9.25M | ﹤0.01% |
230,856
+103,891
| +82% | +$3.91M |
|
1120
WSFS Financial
WSFS
$4.15B
| $9.12M | ﹤0.01% |
201,985
+53,292
| +36% | +$2.32M |
|
1121
Petrobras Class A
PBR.A
$104B
| $9.08M | ﹤0.01% |
609,153
| – | – |
|
1122
CI&T Inc
CINT
$465M
| $9.05M | ﹤0.01% |
2,191,586
-47,929
| -2% | -$216K |
|
1123
Kaspi.kz JSC
KSPI
$18.9B
| $9.03M | ﹤0.01% |
+70,223
| New | +$7.19M |
|
|
ENV
1124
DELISTED
ENVESTNET, INC.
ENV
| $8.97M | ﹤0.01% |
154,843
+48,057
| +45% | +$2.51M |
|
1125
W.P. Carey
WPC
$16.1B
| $8.91M | ﹤0.01% |
157,771
+5,975
| +4% | +$358K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.